Oragenics, Inc. ( OGEN) - Key Metrics
OGEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.57 | -$0.49 | -$0.49 |
| 2026Q1 | $0 | -$0.51 | -$0.51 | -$0.51 |
| 2025Q4 | $0 | -$0.54 | -$0.66 | -$0.66 |
| 2025Q3 | $0 | -$196.46 | -$191.20 | -$191.20 |
| 2025Q2 | $0 | -$310.47 | -$179.61 | -$179.61 |
OGEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.25 |
| 2026Q1 | 0% | -0.27 |
| 2025Q4 | 0% | -0.36 |
| 2025Q3 | 0% | -0.17 |
| 2025Q2 | 0% | -0.31 |
OGEN
Price: $0.55
52 week price:
Earnings Per Share: -1.43 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23200
Market Capitalization: 2.4 million